Literature DB >> 20668014

Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance.

Donald W Cockcroft1.   

Abstract

Direct bronchoprovocation challenges (eg, methacholine), which act directly on a specific airway smooth muscle receptor, are the most commonly performed challenge tests. Cut points have been arbitrarily selected to give high sensitivity and negative predictive values. In subjects with clinically current symptoms (within a few days) who inhale methacholine without deep inhalations, a normal methacholine test (provocative concentration causing a 20% fall in FEV(1) [PC(20)] > 16 mg/mL) rules out (current) asthma with reasonable certainty. A positive test in the moderate or greater range (PC(20) < 1 mg/mL) has high specificity and positive predictive value, comparable to the indirect challenges. Values between these levels are consistent with, but not diagnostic of, asthma. The positive predictive value (for clinical asthma) will increase the closer the PC(20) is to 1 mg/mL, the higher the pretest probability is for asthma and the more the methacholine-induced symptoms resemble the naturally occurring symptoms. Direct challenges are more sensitive and less specific than indirect challenges (exercise, adenosine monophosphate, mannitol, etc).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668014     DOI: 10.1378/chest.10-0088

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

1.  Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.

Authors:  Lioubov I Brueggemann; Priyanka P Kakad; Robert B Love; Julian Solway; Maria L Dowell; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

2.  ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.

Authors:  Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2015-09

3.  Airway hyperresponsiveness in patients with normal spirometry results and symptoms compatible with asthma: Primary care retrospective chart review.

Authors:  Amy Chen; Katrina A D'Urzo; Anthony D D'Urzo
Journal:  Can Fam Physician       Date:  2021-03-16       Impact factor: 3.275

Review 4.  Diagnostic exercise challenge testing.

Authors:  Christopher Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

5.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

Review 6.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

7.  Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.

Authors:  Kathryn Blake; James D Cury; Jobayer Hossain; Kelan Tantisira; Jianwei Wang; Edward Mougey; John Lima
Journal:  Pulm Pharmacol Ther       Date:  2013-02-04       Impact factor: 3.410

8.  Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2014-06-17       Impact factor: 4.200

9.  Bronchial Reactivity and Lung Function After World Trade Center Exposure.

Authors:  Thomas K Aldrich; Jessica Weakley; Sean Dhar; Charles B Hall; Tesha Crosse; Gisela I Banauch; Michael D Weiden; Gabriel Izbicki; Hillel W Cohen; Aanchal Gupta; Camille King; Vasilios Christodoulou; Mayris P Webber; Rachel Zeig-Owens; William Moir; Anna Nolan; Kerry J Kelly; David J Prezant
Journal:  Chest       Date:  2016-07-19       Impact factor: 9.410

10.  Respiratory syncytial virus and reactive airway disease.

Authors:  Matthew T Lotz; Martin L Moore; R Stokes Peebles
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.